Shares of ValiRx plc (LON:VAL – Get Free Report) crossed below its 50 day moving average during trading on Monday. The stock has a 50 day moving average of GBX 0.14 and traded as low as GBX 0.14. ValiRx shares last traded at GBX 0.14, with a volume of 14,034,691 shares traded.
ValiRx Trading Up 4.3%
The firm has a market capitalization of £1.93 million, a P/E ratio of -0.36 and a beta of 0.59. The firm has a 50-day moving average of GBX 0.14 and a two-hundred day moving average of GBX 0.21.
ValiRx (LON:VAL – Get Free Report) last released its earnings results on Tuesday, September 15th. The company reported GBX (0.09) earnings per share (EPS) for the quarter. ValiRx had a negative net margin of 6,548.06% and a negative return on equity of 71.49%. On average, sell-side analysts anticipate that ValiRx plc will post -1.74 EPS for the current fiscal year.
ValiRx Company Profile
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Further Reading
- Five stocks we like better than ValiRx
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
